BLife Therapeutics

is a biotechnology firm that develops and commercializes therapeutics for the treatment of viral infections...
Read more
BLife Therapeutics CEO: Ahmad Doroudian

CEO

Ahmad Doroudian

CEO Approval Rating

90/100

Annual Revenue
<$1M
Employees
<10
Funding
$2.3M
Acquisitions
1

News

Dec 02, 2020
Proactive Investors
BLife Therapeutics: BetterLife Pharma closes private placement of special warrants that raised nearly C$3M
Nov 10, 2020
Proactive Investors
BLife Therapeutics: BetterLife Pharma meets with FDA as it seeks potential approval of AP-003 COVID-19 clinical trials
Nov 04, 2020
BioSpace
BLife Therapeutics: BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial Operations
Oct 28, 2020
GlobalNewswire
Press Release: BLife Therapeutics : BetterLife Provides Important Update on its Australian Clinical Study Design
Oct 28, 2020
MarketScreener
BLife Therapeutics: UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company's Interferon Alpha 2b and Synairgen PLC's Interferon Beta
Oct 20, 2020
Proactive Investors
BLife Therapeutics: BetterLife Pharma launches marketed private placement offering of special warrants for gross proceeds of up to $5 million
Oct 16, 2020
Pharma IQ
BLife Therapeutics: Keeping tabs on Covid-19: BetterLife embraces virtual clinical trials and Novan...
Oct 08, 2020
Proactive Investors
BLife Therapeutics: BetterLife Pharma announces VirTrial as patient monitoring partner for COVID-19 study in Australia to test efficacy of AP-003
Sep 23, 2020
GlobalNewswire
Press Release: BLife Therapeutics : BetterLife Provides Update on OTC Trading Activity
Sep 02, 2020
GlobalNewswire
Press Release: BLife Therapeutics : BetterLife Pharma Announces Dr. Eleanor Fish to Retain Role as Key Scientific Advisor Following Invitation to Join Government COVID-19 Task Force

Trending Companies